Literature DB >> 21773909

Stromal sarcoma of the breast with lung metastases showing a clinical complete response to doxorubicin plus ifosfamide treatment: report of a case.

Aiko Sueta1, Yutaka Yamamoto, Katsuhiko Inoue, Kazumi Kuriwaki, Hirotaka Iwase.   

Abstract

A 29-year-old woman presented with a painful right breast tumor, measuring 15 cm in diameter, which had progressed rapidly over 3 months. Core needle biopsy of the tumor revealed a malignant mesenchymal tumor. A mastectomy was performed, and pathological examination of the tumor showed stromal sarcoma. Solitary pleural dissemination in the right lung was suspected, based on the computed tomography image taken before the operation. Two months after surgery, bilateral multiple lung nodules were demonstrated. Systemic chemotherapy with doxorubicin plus ifosfamide was performed, and 3 months later the lung metastases had disappeared. Moreover, there is still no sign of recurrence at 5 months after the initiation of the chemotherapy. Breast stromal sarcoma is very rare, accounting for less than 1% of mammary neoplasms, and the treatment strategy is not well established, especially regarding chemotherapy. This case demonstrates the effectiveness of chemotherapy with doxorubicin plus ifosfamide for lung metastases from breast stromal sarcoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21773909     DOI: 10.1007/s00595-010-4406-x

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  14 in total

1.  Stromal sarcomas of the breast. A unified approach to connective tissue sarcomas other than cystosarcoma phyllodes.

Authors:  J W BERG; J J DECROSSE; A A FRACCHIA; J FARROW
Journal:  Cancer       Date:  1962 Mar-Apr       Impact factor: 6.860

Review 2.  Chemotherapy for advanced sarcoma: therapeutic decisions and modalities.

Authors:  M L Keohan; R N Taub
Journal:  Semin Oncol       Date:  1997-10       Impact factor: 4.929

Review 3.  The future of sarcoma treatment.

Authors:  J S Biermann; L H Baker
Journal:  Semin Oncol       Date:  1997-10       Impact factor: 4.929

4.  Sarcomas of the breast: a clinicopathologic analysis of ten cases.

Authors:  L Barnes; M Pietruszka
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

5.  Sarcomas and related mesenchymal tumors of the breast.

Authors:  H J Norris; H B Taylor
Journal:  Cancer       Date:  1968-07       Impact factor: 6.860

6.  Primary breast sarcoma: case report.

Authors:  S Hassan; G Adari
Journal:  East Afr Med J       Date:  2004-07

7.  Sarcoma of the breast. A study of 32 patients with reappraisal of classification and therapy.

Authors:  C D Callery; P P Rosen; D W Kinne
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

8.  Sarcoma of the breast: implications for extent of therapy. The M. D. Anderson experience.

Authors:  H Gutman; R E Pollock; M I Ross; R S Benjamin; D A Johnston; N A Janjan; M M Romsdahl
Journal:  Surgery       Date:  1994-09       Impact factor: 3.982

Review 9.  Phyllodes tumors of the breast.

Authors:  S A Khan; S Badve
Journal:  Curr Treat Options Oncol       Date:  2001-04

Review 10.  Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature.

Authors:  C Adem; C Reynolds; J N Ingle; A G Nascimento
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

View more
  1 in total

1.  Are Breast Masses in Teenagers Always Benign? Undifferentiated Mesenchymal Sarcoma in a 14-Year-Old Girl.

Authors:  Guven Tekbas; Tülay Ince; Murat Kapan; Faysal Ekici; Akin Onder; Mehmet Kucukonen; Aslan Bilici; Hatice Gumus
Journal:  Breast Care (Basel)       Date:  2012-04-24       Impact factor: 2.860

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.